GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » GF Value Rank

HYPMY (Hypera) GF Value Rank : 4 (As of Apr. 25, 2025)


View and export this data going back to . Start your Free Trial

What is Hypera GF Value Rank?

Hypera has the GF Value Rank of 4.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of Hypera's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypera's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Hypera's GF Value Rank falls into.


;
;

Hypera GF Value Rank Related Terms

Thank you for viewing the detailed overview of Hypera's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera Business Description

Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and the Non-Retail Market.

Hypera Headlines

From GuruFocus

Hypera SA Acquires Takeda's Portfolio Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2019 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Hypera SA Analyst Day Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Hypera SA - HypeDay Transcript

By GuruFocus Research 02-13-2024

Q3 2021 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024